The results indicated that G6PD changed cell cycle dynamics, facilitated cell proliferation, promoted migration in vitro, and enhanced ccRCC tumor growth in vivo, probably by upregulating Cyclin E1 and MMP9. The gene discussed is MMP9; the disease is nonpapillary renal cell carcinoma.